You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

List of Excipients in API acamprosate calcium


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing acamprosate calcium

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Carilion Materials Management CAMPRAL acamprosate calcium 68151-4760 CELLULOSE, MICROCRYSTALLINE
Carilion Materials Management CAMPRAL acamprosate calcium 68151-4760 CROSPOVIDONE
Carilion Materials Management CAMPRAL acamprosate calcium 68151-4760 MAGNESIUM SILICATE
Carilion Materials Management CAMPRAL acamprosate calcium 68151-4760 MAGNESIUM STEARATE
Carilion Materials Management CAMPRAL acamprosate calcium 68151-4760 METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Try a Trial

Excipients in ANDA-approved (generic) drugs containing acamprosate calcium

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc acamprosate calcium 0093-5352 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc acamprosate calcium 0093-5352 CROSPOVIDONE
Teva Pharmaceuticals USA Inc acamprosate calcium 0093-5352 HYPROMELLOSE 2910
Teva Pharmaceuticals USA Inc acamprosate calcium 0093-5352 MAGNESIUM STEARATE
Teva Pharmaceuticals USA Inc acamprosate calcium 0093-5352 MAGNESIUM TRISILICATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Try a Trial

Detailed excipient profiles for acamprosate calcium

Excipient focus: AMMONIA

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: MAGNESIUM SILICATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MAGNESIUM TRISILICATE

Excipient focus: METHACRYLIC ACID

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

acamprosate calcium drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Company Ingredient NDC
Teva Pharmaceuticals USA Inc acamprosate calcium 0093-5352
Zydus Pharmaceuticals (USA) Inc acamprosate calcium 68382-569
Glenmark Pharmaceuticals Inc USA acamprosate calcium 68462-435
Zydus Lifesciences Limited acamprosate calcium 70771-1057
Mylan Pharmaceuticals Inc acamprosate calcium enteric-coated 0378-6333
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONE K90

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: TALC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - HIPAA-ready chat for life sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group